Program

Schedule RAB Symposium 2020

The schedule of RAB 2020 is continuously updated.

Thursday, Sep 24, 2020
from 15:30Registration
15:30Poster Setup, Refreshments
16:30Welcome Opening
17:00Scientific Program
19:00Get-together
Friday, Sep 25, 2020
from 08:30Registration
09:00Scientific Progam
19:00Social Event

Saturday, Sep 26, 2020
from 08:30Registration
09:00Scientific Program
12:45Wrap-up and Farewell


Scientific Program of the 2nd RAB-Symposium

Registration
Welcome and opening lectures
Welcome note by the Symposium´s Chair
Gabriela Riemekasten
Welcome note by the dean of the senate commitee in medicine (University Lübeck)
Thomas F. Münte
The Mosaik and Kaleidoskope of Autoimmunity
Yehuda Shoenfeld
Network-based analysis reveals signatures of IgG autoantibodies targeting G protein-coupled receptors in health and disease
Gabriela Riemekasten
Get-together
Anti-GPCR ab: advantages, pitfalls and problem in the diagnosis
Functional ab causing psychiatric manifestations: Lessons need to be learned
Yehuda Shoenfeld
Lessons From Anti-TSH-Receptor Autoantibodies: Challenges And Pitfalls In Diagnostics
Simon Lytton
Patterns of 31 new autoantibodies against G protein-coupled receptors and growth factors
Hannah Bittern
Talks from selected abstracts
Coffee and Industrial Exhibition
Are anti-GPCR ab pathogenic?
Diagnostics of beta-adrenergic receptor autoantibodies in chronic heart failure
Fritz Boege
Novel targets in the diagnosis of autoimmune and non-autoimmune diseases
Harald Heidecke
Anti-AT1R ab and autoimmunity to GPCR as cause or contributor to skin fibrosis and interstitial lung disease
Xinhua Yu
Monoclonal anti-AT1R ab from a SSc mouse model: evaluation of their functions
Frank Petersen
Transfer of PBMC from SSc patients to immunodeficient mice leads to the production of autoantibodies against AT1R and ETAR
Xiaoyang Yue
Talks from selected abstracts
Lunch and Industrial Exhibition
Poster Session
Transfer of PBMC from SSc patients to immunodeficient mice leads to the production of autoantibodies against AT1R and ETAR
Xiaoyang Yuea
ß1-adrenergic receptor autoantibody levels are higher in patients with Graves’ hyperthyroidism than in matched healthy controls and decrease after anti-thyroid treatment
Anna Lundgren
Sialylated autoantigen-reactive IgG antibodies attenuate disease development in mouse models of lupus nephritis and rheumatoid arthritis
Marc Ehlers
Autoantibodies targeting G-protein coupled receptors in RA and SLE
Xinhua Yu
Identification and characterization of cytomegalovirus-specific CD8+ T cells in systemic sclerosis
Gesa Balsen
Autoantibodies targeting complement receptors 3a and 5a are decreased in ANCA-associated vasculitis
Sebastian Klapa
Impact of regulatory (auto-)antibodies against G-protein-coupled receptors on blood pressure in women ten years after early-onset preeclampsia
Anna Birukov
Organotropism of anti-CXCR3/4- and anti-ETAR/-AT1R-mediated leukocyte migration in inflammatory and autoimmune disease
Laurence Johanson
Autoantibodies targeting muscarinic acetylcholine receptors: implications on fatigue in systemic sclerosis
Sabine Sommerlatte
Role of anti-alpha-adrenoceptor autoantibodies and leukocytic alpha-adrenoceptors in primary Raynaud’s phenomenon
Catharina Frahm
Autoantibodies in serum of systemic scleroderma patients: peptide-based epitope mapping indicates increased binding to cytoplasmic domains of CXCR3
Ann-Katrin Regensburger
Detection and functional characterization of angiotensin receptor Type 1 autoantibodies: establishment and clinical translation
Valérie Boivin-Jahns
Inflamed tissue contributes to the emergence of auto-reactivity in granulomatosis with polyangiitis
Gesche Weppner
Patterns of 31 new autoantibodies against G protein-coupled receptors and growth factors
Susanne Schinke
New insights into the diagnostics of autoantibodies against G-protein receptors – pitfalls in the autoantibody detection
Annekathrin Haberland
Network-based analysis reveals signatures of IgG autoantibodies targeting G protein-coupled receptors in healthy and diseases
Gabriela Riemekasten
Signaling of anti-GPCR ab: can we identify novel targets?
Signaling and GPCR biology using cell models
Aurelie Philippe
Lessons from dermatology: Anti-Dsg1/3 und anti-BP180-induced signaling
Ralf Ludwig
Role of antibodies against PAR-1 and PAR-2 in cancer in the kidney transplant recipients
Rusan Catar
Sialylated autoantigen-reactive IgG antibodies attenuate disease development in mouse models of lupus nephritis and rheumatoid arthritis
Marc Ehlers
Autoantibodies targeting complement receptors 3a and 5a are decreased in ANCA-associated vasculitis
Sebastian Klapa
Impact of regulatory (auto-)antibodies against G-protein-coupled receptors on blood pressure in women ten years after early-onset preeclampsia
Ralf Dechend
Talks from selected abstracts
Coffee and Industrial Exhibition
Anti-GPCR ab as marker for diseases and therapeutic responses
Antibodies against complement receptors: impact in pathophysiology?
Christian Karsten
Anti-GPCR ab in atherosclerosis
Zouhair Aherrahrou
Immunoadsorption in Vascular Dementia - a novel approach to Alzheimer´s Disease?
Hans Grabe
First results of the prospective ETiCS: inflammation rather than ischemia triggers the development of cardiac GPCR-autoantibodies
Roland Jahns
Talks from selected abstracts
Social Event with Dinner
Classic concert by participants
Restaurant Miera
How to target effects of functional antibodies
Chronic Fatigue-Syndrom and Apherese
Carmen Scheibenbogen
The aptamer BC 007 completely neutralizes agonistic autoantibodies directed against ß1-adrenoceptors: Results of a phase 1 trial
Niels-Peter Becker
Agonistic antibody disesaes = Autoimmune diseases ? - From bench to bedside
Rudolf Kunze
Detection and functional characterization of angiotensin receptor Type 1 autoantibodies: establishment and clinical translation
Valérie Boivin-Jahns
Talks from selected abstracts
Coffee and Industrial Exhibition
Summary and Closing Remarks
Challenges in the research of anti-GPCR ab
Duska Dragun
Closing Remarks
Transfer of PBMC from SSc patients to immunodeficient mice leads to the production of autoantibodies against AT1R and ETAR
Xiaoyang Yuea
ß1-adrenergic receptor autoantibody levels are higher in patients with Graves’ hyperthyroidism than in matched healthy controls and decrease after anti-thyroid treatment
Anna Lundgren
Sialylated autoantigen-reactive IgG antibodies attenuate disease development in mouse models of lupus nephritis and rheumatoid arthritis
Marc Ehlers
Autoantibodies targeting G-protein coupled receptors in RA and SLE
Xinhua Yu
Identification and characterization of cytomegalovirus-specific CD8+ T cells in systemic sclerosis
Gesa Balsen
Autoantibodies targeting complement receptors 3a and 5a are decreased in ANCA-associated vasculitis
Sebastian Klapa
Impact of regulatory (auto-)antibodies against G-protein-coupled receptors on blood pressure in women ten years after early-onset preeclampsia
Anna Birukov
Organotropism of anti-CXCR3/4- and anti-ETAR/-AT1R-mediated leukocyte migration in inflammatory and autoimmune disease
Laurence Johanson
Autoantibodies targeting muscarinic acetylcholine receptors: implications on fatigue in systemic sclerosis
Sabine Sommerlatte
Role of anti-alpha-adrenoceptor autoantibodies and leukocytic alpha-adrenoceptors in primary Raynaud’s phenomenon
Catharina Frahm
Autoantibodies in serum of systemic scleroderma patients: peptide-based epitope mapping indicates increased binding to cytoplasmic domains of CXCR3
Ann-Katrin Regensburger
Detection and functional characterization of angiotensin receptor Type 1 autoantibodies: establishment and clinical translation
Valérie Boivin-Jahns
Inflamed tissue contributes to the emergence of auto-reactivity in granulomatosis with polyangiitis
Gesche Weppner
Patterns of 31 new autoantibodies against G protein-coupled receptors and growth factors
Susanne Schinke
New insights into the diagnostics of autoantibodies against G-protein receptors – pitfalls in the autoantibody detection
Annekathrin Haberland
Network-based analysis reveals signatures of IgG autoantibodies targeting G protein-coupled receptors in healthy and diseases
Gabriela Riemekasten